Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-01-09 Sale | 2024-01-11 5:06 pm | OptimizeRx Corp | OPRX | Odence-Ford Marion General Counsel and CCO | 4,000 | $15.19 | $60,751 | 11,114 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-04-15 Option Award | 2024-04-17 5:22 pm | N/A N/A | OptimizeRx Corp | OPRX | FEBBO WILLIAM J CEO | 60,000 | $0 | 538,144 (Direct) | View |
| 2024-03-01 Tax Withholding | 2024-03-06 4:20 pm | N/A N/A | OptimizeRx Corp | OPRX | Silvestro Stephen L Chief Commercial Officer | 668 | $15.95 | 7,884 (Direct) | View |
| 2024-03-01 Exercise | 2024-03-06 4:20 pm | N/A N/A | OptimizeRx Corp | OPRX | Silvestro Stephen L Chief Commercial Officer | 1,927 | $0 | 7,884 (Direct) | View |
| 2024-03-01 Tax Withholding | 2024-03-06 4:19 pm | N/A N/A | OptimizeRx Corp | OPRX | Odence-Ford Marion General Counsel and CCO | 268 | $15.95 | 15,002 (Direct) | View |
| 2024-03-01 Exercise | 2024-03-06 4:19 pm | N/A N/A | OptimizeRx Corp | OPRX | Odence-Ford Marion General Counsel and CCO | 771 | $0 | 15,002 (Direct) | View |
| 2023-12-19 Option Award | 2024-02-21 6:25 pm | N/A 2026-12-19 | OptimizeRx Corp | OPRX | Besch Doug Chief Product Officer | 11,784 | $0 | 11,784 (Direct) | View |
| 2023-12-19 Option Award | 2024-02-21 6:24 pm | N/A 2026-12-19 | OptimizeRx Corp | OPRX | Stelmakh Edward CFO/COO | 31,422 | $0 | 31,422 (Direct) | View |
| 2023-12-19 Option Award | 2024-02-21 6:23 pm | 2024-12-19 2026-12-19 | OptimizeRx Corp | OPRX | Odence-Ford Marion General Counsel and CCO | 23,566 | $0 | 23,566 (Direct) | View |
| 2023-12-19 Option Award | 2024-02-21 6:22 pm | N/A 2026-12-19 | OptimizeRx Corp | OPRX | Silvestro Stephen L Chief Commercial Officer | 39,278 | $0 | 39,278 (Direct) | View |
| 2024-02-11 Tax Withholding | 2024-02-13 6:16 pm | N/A N/A | OptimizeRx Corp | OPRX | Odence-Ford Marion General Counsel and CCO | 1,386 | $15.39 | 29,728 (Direct) | View |
| 2024-02-11 Exercise | 2024-02-13 6:16 pm | N/A N/A | OptimizeRx Corp | OPRX | Odence-Ford Marion General Counsel and CCO | 4,000 | $0 | 29,728 (Direct) | View |
| 2024-02-02 Option Award | 2024-02-06 7:53 pm | N/A N/A | OptimizeRx Corp | OPRX | KLEMA CATHY Director | 5,109 | $0 | 5,109 (Direct) | View |
| 2024-01-09 Exercise | 2024-01-18 5:56 pm | N/A N/A | OptimizeRx Corp | OPRX | FEBBO WILLIAM J CEO | 9,628 | $0 | 478,144 (Direct) | View |
| 2024-01-09 Tax Withholding | 2024-01-18 5:56 pm | N/A N/A | OptimizeRx Corp | OPRX | FEBBO WILLIAM J CEO | 2,884 | $13.25 | 478,144 (Direct) | View |
| 2023-11-08 Exercise | 2023-11-13 2:32 pm | N/A N/A | OptimizeRx Corp | OPRX | Odence-Ford Marion General Counsel and CCO | 1,785 | $0 | 16,899 (Direct) | View |
| 2023-11-08 Tax Withholding | 2023-11-13 2:32 pm | N/A N/A | OptimizeRx Corp | OPRX | Odence-Ford Marion General Counsel and CCO | 524 | $9.21 | 16,899 (Direct) | View |
| 2023-11-01 Option Award | 2023-11-03 10:49 am | N/A 2028-11-01 | OptimizeRx Corp | OPRX | Greco Theresa Chief Commercial Officer | 54,277 | $0 | 72,796 (Direct) | View |
Ownership | 2023-10-30 4:06 pm | N/A N/A | OptimizeRx Corp | OPRX | Greco Theresa Chief Commercial Officer | 0 | $0 | 21,089 (Direct) | View |
| 2023-10-11 Tax Withholding | 2023-10-12 2:18 pm | N/A N/A | OptimizeRx Corp | OPRX | Stelmakh Edward CFO/COO | 2,066 | $7.15 | 54,202 (Direct) | View |
| 2022-10-11 Exercise | 2023-10-12 2:18 pm | N/A N/A | OptimizeRx Corp | OPRX | Stelmakh Edward CFO/COO | 22,597 | $0 | 54,202 (Direct) | View |
| 2023-10-03 Exercise | 2023-10-06 2:47 pm | N/A N/A | OptimizeRx Corp | OPRX | Odence-Ford Marion General Counsel and CCO | 6,649 | $0 | 27,151 (Direct) | View |
| 2023-10-03 Tax Withholding | 2023-10-06 2:47 pm | N/A N/A | OptimizeRx Corp | OPRX | Odence-Ford Marion General Counsel and CCO | 1,952 | $7.06 | 27,151 (Direct) | View |
| 2023-10-03 Exercise | 2023-10-06 2:47 pm | N/A N/A | OptimizeRx Corp | OPRX | Silvestro Stephen L Chief Commercial Officer | 6,649 | $0 | 17,995 (Direct) | View |
| 2023-10-03 Tax Withholding | 2023-10-06 2:47 pm | N/A N/A | OptimizeRx Corp | OPRX | Silvestro Stephen L Chief Commercial Officer | 1,952 | $7.06 | 17,995 (Direct) | View |
| 2023-10-03 Exercise | 2023-10-06 2:47 pm | N/A N/A | OptimizeRx Corp | OPRX | Stelmakh Edward CFO/COO | 16,662 | $0 | 50,432 (Direct) | View |
| 2023-10-03 Tax Withholding | 2023-10-06 2:47 pm | N/A N/A | OptimizeRx Corp | OPRX | Stelmakh Edward CFO/COO | 4,117 | $7.06 | 50,432 (Direct) | View |
| 2023-10-03 Exercise | 2023-10-06 2:47 pm | N/A N/A | OptimizeRx Corp | OPRX | Besch Doug Chief Product Officer | 3,324 | $0 | 10,497 (Direct) | View |
| 2023-10-03 Tax Withholding | 2023-10-06 2:47 pm | N/A N/A | OptimizeRx Corp | OPRX | Besch Doug Chief Product Officer | 976 | $7.06 | 10,497 (Direct) | View |
| 2023-06-07 Exercise | 2023-08-18 10:03 am | N/A N/A | OptimizeRx Corp | OPRX | HALAS GUS D Director | 4,637 | $0 | 80,926 (Direct) | View |
| 2023-06-07 Option Award | 2023-08-18 10:03 am | N/A N/A | OptimizeRx Corp | OPRX | HALAS GUS D Director | 10,061 | $0 | 80,926 (Direct) | View |
| 2023-06-07 Exercise | 2023-08-18 09:33 am | N/A N/A | OptimizeRx Corp | OPRX | Spangler Patrick D Director | 4,637 | $0 | 32,181 (Direct) | View |
| 2023-06-07 Option Award | 2023-08-18 09:33 am | N/A N/A | OptimizeRx Corp | OPRX | Spangler Patrick D Director | 10,061 | $0 | 32,181 (Direct) | View |
| 2023-06-07 Exercise | 2023-08-18 09:31 am | N/A N/A | OptimizeRx Corp | OPRX | Lang James Paul Director | 4,637 | $0 | 54,758 (Direct) | View |
| 2023-06-07 Option Award | 2023-08-18 09:31 am | N/A N/A | OptimizeRx Corp | OPRX | Lang James Paul Director | 10,061 | $0 | 54,758 (Direct) | View |
| 2023-06-07 Exercise | 2023-08-18 09:29 am | N/A N/A | OptimizeRx Corp | OPRX | Vos Ellen O'Connor Director | 4,637 | $0 | 49,488 (Direct) | View |
| 2023-06-07 Option Award | 2023-08-18 09:29 am | N/A N/A | OptimizeRx Corp | OPRX | Vos Ellen O'Connor Director | 10,061 | $0 | 49,488 (Direct) | View |
| 2023-06-07 Exercise | 2023-08-18 09:28 am | N/A N/A | OptimizeRx Corp | OPRX | WASSON GREGORY D Director | 4,637 | $0 | 34,029 (Direct) | View |
| 2023-06-07 Option Award | 2023-08-18 09:28 am | N/A N/A | OptimizeRx Corp | OPRX | WASSON GREGORY D Director | 10,061 | $0 | 34,029 (Direct) | View |
| 2023-04-18 Option Award | 2023-04-20 3:15 pm | N/A N/A | OptimizeRx Corp | OPRX | FEBBO WILLIAM J CEO | 248,383 | $0 | 248,383 (Direct) | View |
| 2023-03-30 Exercise | 2023-04-03 12:22 pm | N/A N/A | OptimizeRx Corp | OPRX | Lang James Paul Director | 657 | $0 | 40,717 (Direct) | View |
| 2023-03-30 Exercise | 2023-04-03 12:22 pm | N/A N/A | OptimizeRx Corp | OPRX | HALAS GUS D Director | 657 | $0 | 66,885 (Direct) | View |
| 2023-03-31 Exercise | 2023-04-03 12:22 pm | N/A N/A | OptimizeRx Corp | OPRX | WASSON GREGORY D Director | 657 | $0 | 19,988 (Direct) | View |
| 2023-03-31 Exercise | 2023-04-03 12:19 pm | N/A N/A | OptimizeRx Corp | OPRX | Spangler Patrick D Director | 657 | $0 | 18,140 (Direct) | View |
| 2023-03-31 Exercise | 2023-04-03 12:18 pm | N/A N/A | OptimizeRx Corp | OPRX | Vos Ellen O'Connor Director | 657 | $0 | 35,447 (Direct) | View |
| 2022-10-11 Exercise | 2023-03-30 12:19 pm | N/A N/A | OptimizeRx Corp | OPRX | Stelmakh Edward CFO/COO | 8,221 | $0 | 21,125 (Direct) | View |
| 2022-10-11 Tax Withholding | 2023-03-30 12:19 pm | N/A N/A | OptimizeRx Corp | OPRX | Stelmakh Edward CFO/COO | 6,539 | $15.17 | 21,125 (Direct) | View |
| 2023-03-01 Exercise | 2023-03-03 3:41 pm | N/A N/A | OptimizeRx Corp | OPRX | Odence-Ford Marion General Counsel and CCO | 771 | $0 | 10,698 (Direct) | View |
| 2023-03-01 Tax Withholding | 2023-03-03 3:41 pm | N/A N/A | OptimizeRx Corp | OPRX | Odence-Ford Marion General Counsel and CCO | 268 | $18.11 | 10,698 (Direct) | View |
| 2023-03-01 Exercise | 2023-03-03 3:40 pm | N/A N/A | OptimizeRx Corp | OPRX | Silvestro Stephen L Chief Commercial Officer | 1,927 | $0 | 8,314 (Direct) | View |
| 2023-03-01 Tax Withholding | 2023-03-03 3:40 pm | N/A N/A | OptimizeRx Corp | OPRX | Silvestro Stephen L Chief Commercial Officer | 668 | $18.11 | 8,314 (Direct) | View |
| 2023-03-01 Exercise | 2023-03-03 3:31 pm | N/A N/A | OptimizeRx Corp | OPRX | Inman Todd Chief Technology Officer | 771 | $0 | 2,080 (Direct) | View |
| 2023-03-01 Tax Withholding | 2023-03-03 3:31 pm | N/A N/A | OptimizeRx Corp | OPRX | Inman Todd Chief Technology Officer | 233 | $18.11 | 2,080 (Direct) | View |
| 2023-02-11 Exercise | 2023-02-14 11:32 am | N/A N/A | OptimizeRx Corp | OPRX | Odence-Ford Marion General Counsel and CCO | 4,000 | $0 | 20,653 (Direct) | View |
| 2023-02-11 Tax Withholding | 2023-02-14 11:32 am | N/A N/A | OptimizeRx Corp | OPRX | Odence-Ford Marion General Counsel and CCO | 1,422 | $17.34 | 20,653 (Direct) | View |
| 2023-01-07 Exercise | 2023-01-31 4:50 pm | N/A N/A | OptimizeRx Corp | OPRX | FEBBO WILLIAM J CEO | 9,628 | $0 | 481,028 (Direct) | View |
| 2022-12-30 Exercise | 2023-01-04 4:10 pm | N/A N/A | OptimizeRx Corp | OPRX | HALAS GUS D Director | 409 | $0 | 65,571 (Direct) | View |
| 2022-12-30 Exercise | 2023-01-04 4:07 pm | N/A N/A | OptimizeRx Corp | OPRX | WASSON GREGORY D Director | 409 | $0 | 18,674 (Direct) | View |
| 2022-12-30 Exercise | 2023-01-04 4:06 pm | N/A N/A | OptimizeRx Corp | OPRX | Vos Ellen O'Connor Director | 409 | $0 | 34,133 (Direct) | View |